Holen Sie sich die Stockscreener-App
29.59
2.92%
0.84
Handel nachbörslich:
29.59
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - TradingView
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know | FinancialContent - FinancialContent
Enovis price target lowered to $58 from $70 at Canaccord - MSN
UBS Lowers PT on Enovis Corporation (ENOV) to $57 From $65, Keeps a Buy Rating - MSN
DENTSPLY SIRONA, Replimune Group, and Enovis Analysts Maintain Neutral Ratings - AInvest
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know - TradingView
Full technical analysis of Enovis Corporation stockTop Stock Picks with Forecast Accuracy - Newser
Forecasting Enovis Corporation price range with options dataMomentum Stocks with Breakout Potential - Newser
Enovis to Present at Three Upcoming Investor Conferences - MSN
Is Enovis Corporation meeting your algorithmic filter criteriaEntry Zone Watchlist With Momentum Focus - Newser
How to recover losses in Enovis Corporation stockMulti-Bagger Detection with Trend Tools - Newser
Will Enovis Corporation outperform the marketRisk Aware Trading Ideas with Alert Levels - Newser
Enovis Corporation Reports Strong Growth Amid Challenges - TipRanks
Enovis Corp's December 2026 Options Begin Trading - AInvest
Quantitative breakdown of Enovis Corporation recent moveFree AI Powered High Return Stock Calls - Newser
Using Python tools to backtest Enovis Corporation strategiesFree Swing Trading Plan With Smart Signals - Newser
How to interpret RSI for Enovis Corporation stockFast Entry Strategy with Price Prediction - Newser
Order flow analysis tools used on Enovis CorporationFree Real Market Momentum Signal Generator - Newser
Enovis raises 2025 revenue guidance to $2.275B amid CEO transition and product momentum - MSN
What institutions are buying Enovis Corporation stock nowWeekly Price Target Forecast and Alerts - Newser
What does recent volatility data suggest for Enovis CorporationInvestment Life Cycle Planning Summary - Newser
Tick level data insight on Enovis Corporation volatilityInvestment Roadmap for High Potential Stocks - Newser
Needham & Company LLC Cuts Enovis (NYSE:ENOV) Price Target to $49.00 - Defense World
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
Earnings Release: Here's Why Analysts Cut Their Enovis Corporation (NYSE:ENOV) Price Target To US$53.40 - Yahoo Finance
Enovis Corporation (NYSE:ENOV) Q2 2025 Earnings Call Transcript - MSN
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $41 - 富途牛牛
Does Enovis Corporation stock pay reliable dividendsFree Growth Based Investment Plan Guidance - Newser
Enovis Corporation Reports Q2 2025 Financial Results - The Globe and Mail
Enovis 2025 Q2 Earnings Net Loss Widens Sharply - AInvest
Enovis' Q2 2025: Unraveling Contradictions in Recon Growth, Market Dynamics, and Financial Strategy - AInvest
Canaccord Genuity Adjusts Price Target for Enovis (ENOV) to $58. - GuruFocus
Enovis: UBS maintains Buy rating, lowers PT to $57 from $65. - AInvest
Enovis to Attend Key Investor Conferences in August and September - AInvest
Enovis (ENOV) Raises Revenue Guidance but Net Loss Widens Could Profitability Take Priority Next? - simplywall.st
Enovis Corp Inc. (ENOV) Price Performance and Its Relation to the Tech Industry - investchronicle.com
Enovis' Strategic Investor Engagement and Institutional Sentiment Shifts: A Blueprint for Medical Tech Resilience - AInvest
Enovis to Participate in Upcoming Investor Conferences - The Manila Times
UBS Adjusts Enovis Price Target to $57 From $65, Maintains Buy Rating - MarketScreener
Canaccord Genuity lowers Enovis stock price target to $58 on tariff impacts - Investing.com Nigeria
Enovis Corporation (ENOV): Navigating Tariffs and Innovation to Cement Long-Term Resilience - AInvest
Enovis Raises 2025 Revenue Guidance to $2.275B Amid CEO Transition and Product Momentum - AInvest
Enovis Corp (ENOV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Updated Guidance By GuruFocus - Investing.com Canada
Enovis Corp (ENOV) Q2 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates - sharewise.com
Why Enovis Corporation stock attracts strong analyst attentionLong-Term Growth Trend Summary With Confidence - Newser
Needham Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $49 - 富途牛牛
Needham lowers Enovis stock price target to $49 on peer multiple contraction - Investing.com Canada
Enovis' Q2 2025 Earnings Outperformance and Strategic Momentum: A Re-Rating in the Making? - AInvest
Enovis Exceeds Q2 Sales Estimates, Stock Jumps 10.3% - AInvest
Enovis: Strong Financial Performance and Positive Outlook Justify Buy Rating - TipRanks
Enovis’s (NYSE:ENOV) Q2 Sales Beat Estimates, Stock Jumps 10.3% - Yahoo Finance
Earnings call transcript: Enovis Q2 2025 beats expectations, stock surges - Investing.com
Earnings call transcript: Enovis Q2 2025 beats expectations, stock surges By Investing.com - Investing.com UK
Enovis: Q2 Earnings Snapshot - The Washington Post
Enovis Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Enovis (ENOV) Surges 10% on Earnings Beat and Strategic Momentum—What’s Fueling This Rally? - AInvest
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):